Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
[Protocol for neurophysiological studies of the pelvic floor to appraise anorectal dysfunction in patients with multiple sclerosis].
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Transdermal immunotherapy: Past, present and future.
[Epidemiology of multiple sclerosis].
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »